<DOC>
	<DOCNO>NCT02687451</DOCNO>
	<brief_summary>The purpose study evaluate efficacy , tolerability , safety pharmacokinetics Oxymorphone HCl analgesic acute moderate severe post-operative pain pediatric subject .</brief_summary>
	<brief_title>Clinical Study Evaluate Effectiveness , Safety , Tolerability Oxymorphone Immediate Release ( IR ) Oral Liquid Post Surgical Pediatric Subjects</brief_title>
	<detailed_description />
	<mesh_term>Pain , Postoperative</mesh_term>
	<mesh_term>Acute Pain</mesh_term>
	<mesh_term>Oxymorphone</mesh_term>
	<criteria>1 . Is male female &lt; 2 year age time surgery . 2 . Must weigh least 3 kg . 3 . Is schedule surgical procedure opioid analgesia need manage postoperative pain least 18 hour follow intraoperative and/or postoperative IV analgesia . 4 . Is generally healthy document medical history ; physical examination ( include , limited , cardiovascular , gastrointestinal , respiratory , central nervous system ) ; vital sign assessment ; 12lead electrocardiogram ( EKGs ) ; clinical laboratory assessment ; general observation . Any abnormality deviation acceptable range might consider clinically relevant study physician investigator evaluate casebycase basis , agree upon Principal Investigator ( subinvestigator ) , document study file enrol subject study . 5 . The subject 's parent guardian inform nature study provide write informed consent . Postoperative : 6 . Is anticipated require analgesic regimen use shortacting opioid ( nonoxycodone nonoxymorphone ) analgesic surgery ( accord standard care ( SOC ) define protocol ) . 7 . Is inpatient expect hospitalize 24 hour dose study drug . 8 . Has indwell access catheter blood sampling . 9 . Has demonstrate ability tolerate clear fluid follow surgery accord SOC institution . All infant child able demonstrate strong suck swallow reflex neurologic alertness stability sufficient handle oral secretion . The ability tolerate small amount ( 1 2 oz . ) clear liquid without emesis ( 30 60 minute ) would support readiness study participation oral intake physician order diet advanced clear liquid subject ingested fluid mouth without nausea vomiting . 1 . Has presence history clinically significant disorder involve cardiovascular , respiratory , renal , gastrointestinal , immunologic , hematologic , endocrine , nervous system ( ) psychiatric disease would contraindicate participation , determine Investigator . 2 . Has clinical laboratory test result outside accepted range confirm upon reexamination deem clinically significant . 3 . Has clinically significant illness condition time dose study drug would contraindicate participation , determine Investigator . 4 . Has life expectancy &lt; 8 week . 5 . For age group A B : Has malabsorption , gastroenterologic , abdominal condition would interfere absorption study drug . 6 . Has evidence increase intracranial pressure . 7 . Has respiratory condition require intubation result active bronchiolitis , asthma , stridor , difficulty breathe due congestion increase nasal secretion , include oxygen ( O2 ) saturation â‰¤92 % . 8 . Has history seizure . 9 . Subject ( and/or mother subject nursing ) use medication action characteristic monoamine oxidase inhibitor ( MAOIs ) within 14 day start study drug prohibit . Standard daily pediatric multivitamin may take enrollment study restrict study . 10 . Subject ( and/or mother subject nursing ) receive preoperative opioids 72 consecutive hour . 11 . Subject ( and/or mother subject nursing ) receive oxycodone oxymorphone within 48 hour prior screen . 12 . Subject ( and/or mother subject nursing ) ingest caffeine xanthinecontaining product ( eg , theophylline ) within 48 hour dose . These product also prohibit period blood sample collect . 13 . Has history relevant drug allergy , food allergy , ( ie , allergy oxymorphone opioid analgesic ) could interfere study . 14 . Parent legal guardian unable provide consent reason ( eg , mental physical disability , language barrier , unavailable ) . 15 . Subject ( and/or mother subject nursing ) participate clinical study unapproved drug within previous 30 day . 16 . Is suitable entry study opinion Investigator .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>2 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Surgical Pain</keyword>
	<keyword>Acute Post-Surgical Pain</keyword>
</DOC>